p53-MDM2 (AstraZeneca)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namep53-MDM2 (AstraZeneca)
Drug Alias NameMDM2/p53 inhibitors (AstraZeneca)MDM2/p53 inhibitors (Zeneca)p53-MDM2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeneca Pharmaceuticals Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca PlcZeneca Pharmaceuticals Group
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A